Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
CRISPR/Cas technology has revolutionized the fields of the genome- and epigenome-editing by supplying unparalleled control over genomic sequences and expression. Lentiviral vector (LV) systems are one of the main delivery vehicles for the CRISPR/Cas systems due to (<i>i</i>) its ability...
Main Authors: | Wendy Dong, Boris Kantor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/7/1288 |
Similar Items
-
Lentiviral delivery of CRISPR Cas9 prime editing system for cystic fibrosis
by: Satyapertiwi, D
Published: (2024) -
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
by: Naoya Uchida, et al.
Published: (2021-06-01) -
Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene Editing
by: Dimitrios L. Wagner, et al.
Published: (2022-06-01) -
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
by: Joseph Edward Rittiner, et al.
Published: (2020-08-01) -
The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes
by: Nicolas Merienne, et al.
Published: (2017-09-01)